Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Br J Pharmacol ; 162(3): 566-73, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20880026

RESUMO

BACKGROUND AND PURPOSE: Diaphragm muscle weakness occurs in patients with heart failure (HF) and is associated with exercise intolerance and increased mortality. Reduced sensitivity of diaphragm fibres to calcium contributes to diaphragm weakness in HF. Here we have investigated the ability of the calcium sensitizer levosimendan to restore the reduced calcium sensitivity of diaphragm fibres from rats with HF. EXPERIMENTAL APPROACH: Coronary artery ligation in rats was used as an animal model for HF. Sham-operated rats served as controls. Fifteen weeks after induction of HF or sham operations animals were killed and muscle fibres were isolated from the diaphragm. Diaphragm fibres were skinned and activated with solutions containing incremental calcium concentrations and 10 µM levosimendan or vehicle (0.02% DMSO). Developed force was measured at each calcium concentration, and force-calcium concentration relationships were plotted. KEY RESULTS: Calcium sensitivity of force generation was reduced in diaphragm muscle fibres from HF rats, compared with fibres from control rats (P < 0.01). Maximal force generation was ∼25% lower in HF diaphragm fibres than in control fibres (P < 0.05). Levosimendan significantly increased calcium sensitivity of force generation in diaphragm fibres from HF and control rats, without affecting maximal force generation. CONCLUSIONS AND IMPLICATIONS: Levosimendan enhanced the force generating capacity of diaphragm fibres from HF rats by increasing the sensitivity of force generation to calcium concentration. These results provide strong support for testing the effect of calcium sensitizers on diaphragm muscle weakness in patients with HF.


Assuntos
Antiarrítmicos/farmacologia , Cálcio/farmacologia , Diafragma/fisiologia , Insuficiência Cardíaca/fisiopatologia , Hidrazonas/farmacologia , Contração Muscular/efeitos dos fármacos , Fibras Musculares Esqueléticas/efeitos dos fármacos , Piridazinas/farmacologia , Animais , Diafragma/efeitos dos fármacos , Humanos , Masculino , Fibras Musculares Esqueléticas/química , Fibras Musculares Esqueléticas/fisiologia , Debilidade Muscular , Cadeias Pesadas de Miosina/análise , Ratos , Ratos Wistar , Simendana
2.
Biochem Biophys Res Commun ; 237(1): 177-81, 1997 Aug 08.
Artigo em Inglês | MEDLINE | ID: mdl-9266853

RESUMO

The cytoplasmic protein alpha-catenin plays a crucial role in E-cadherin mediated cell-cell adhesion by binding E-cadherin to the cytoskeleton via beta- or gamma-catenin and actin. Functional loss of one of these interacting components leads to decreased cell-cell adhesion, and therefore to loss of epithelial integrity. Northern analysis revealed two distinct alphaE-catenin transcripts in different cell lines, whereas apparently only one protein is expressed. Because of the biological importance of this protein we sought to molecularly characterize the differences between the two observed transcripts. cDNA cloning and sequence analysis revealed the earlier described 3.4 kb alphaE-catenin transcript and an alphaE-catenin transcript of approximately 3.8 kb. This larger transcript contains a 321 bp extension in the 3'UTR sequence, which probably arises as a result of alternative polyadenylation. Considering the presence of AU-rich sequences in the extension, it may be involved in mRNA stability.


Assuntos
Caderinas/biossíntese , Proteínas do Citoesqueleto/biossíntese , Transcrição Gênica , Sequência de Bases , Linhagem Celular , Clonagem Molecular , Proteínas do Citoesqueleto/genética , Primers do DNA , DNA Complementar , Éxons , Biblioteca Gênica , Humanos , Masculino , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Próstata , Proteínas Recombinantes/biossíntese , alfa Catenina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA